News
CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
Approved in June for people at high risk of HIV, Yeztugo was shown to be nearly 100% effective at preventing infection in ...
The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention ...
Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...
Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.
Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.
GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, at a cash price of $499 per month.
Located at San Pedro Dr. and Central Ave., the management at Sandia Pharmacy said they opened after people in the community said they needed options.
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding to the list of conditions for which the blockbuster therapy is ...
The state plans to end Medicaid coverage of popular glucagon-like peptide-1 drugs such as Wegovy, used for obesity and weight loss, Sangvai said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results